Janssen Agrees With Creation Of Invokana MDL, Transfer To New Jersey
Mealey's (October 17, 2016, 12:40 PM EDT) -- WASHINGTON, D.C. — Janssen Pharmaceuticals Inc. on Oct. 12 said it agrees with some plaintiffs that at least 57 federal lawsuits alleging kidney failure or ketoacidosis from the diabetes drug Invokana should be centralized in a multidistrict litigation (In Re: Invokana [Canagliflozin] Products Liability Litigation, MDL Docket No. 2750, JMPDL).
(Brief available. Document #28-161020-005B.)
In a response filed with the Judicial Panel on Multidistrict Litigation, Janssen agreed with the moving plaintiffs that the MDL should be assigned to Judge Brian Martinotti of the U.S. District Court...